In 2023, Croatia topped the list in global cardiovascular medicine sales per capita, followed by South Korea and Portugal. Significant growth in South Korea was observed with a 9.06% increase, whereas Hungary, Austria, and Norway saw slight declines. The United Kingdom experienced a negligible decrease, contrasting with New Zealand's notable 7.66% rise. Costa Rica's sales also grew modestly. Overall, the market shows varying trends, with some countries demonstrating significant sales growth.
Future trends to watch include the impact of aging populations in developed countries, increased healthcare awareness, and advancements in cardiovascular treatments which may further influence sales dynamics globally. Emerging markets may also play a crucial role in the growth trajectory.
Top countries in Cardiovascular System Medicine Sales by Country
# | 10 Countries | US Dollars PPP Per Capita | Last Year | YoY | 5-years CAGR | |
---|---|---|---|---|---|---|
1 | 1 Croatia | 525.4 | 2023 | +0.98% | +3.58% | View data |
2 | 2 South Korea | 131.3 | 2023 | +8.07% | +9.06% | View data |
3 | 3 Portugal | 109.7 | 2023 | +5.89% | +5.48% | View data |
4 | 4 Spain | 93.8 | 2023 | +4.45% | +3.81% | View data |
5 | 5 Germany | 80.1 | 2023 | +0.12% | +1.46% | View data |
6 | 6 Hungary | 63.5 | 2023 | -1.24% | -1.53% | View data |
7 | 7 Austria | 55.7 | 2023 | -1.42% | -1.96% | View data |
8 | 8 Estonia | 47.9 | 2023 | 0% | +2.04% | View data |
9 | 9 Sweden | 35.6 | 2023 | -0.28% | +4.77% | View data |
10 | 10 Norway | 33.1 | 2023 | -2.36% | -0.54% | View data |